These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23410495)

  • 41. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    von Mering GO; Arant CB; Wessel TR; McGorray SP; Bairey Merz CN; Sharaf BL; Smith KM; Olson MB; Johnson BD; Sopko G; Handberg E; Pepine CJ; Kerensky RA;
    Circulation; 2004 Feb; 109(6):722-5. PubMed ID: 14970106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation study.
    Rutledge T; Reis SE; Olson M; Owens J; Kelsey SF; Pepine CJ; Mankad S; Rogers WJ; Bairey Merz CN; Sopko G; Cornell CE; Sharaf B; Matthews KA;
    Psychosom Med; 2004; 66(6):882-8. PubMed ID: 15564353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the "suspected CAD" cohort of the european cardiovascular magnetic resonance registry.
    Moschetti K; Petersen SE; Pilz G; Kwong RY; Wasserfallen JB; Lombardi M; Korosoglou G; Van Rossum AC; Bruder O; Mahrholdt H; Schwitter J
    J Cardiovasc Magn Reson; 2016 Jan; 18():3. PubMed ID: 26754743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
    Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study.
    Krantz DS; Whittaker KS; Francis JL; Rutledge T; Johnson BD; Barrow G; McClure C; Sheps DS; York K; Cornell C; Bittner V; Vaccarino V; Eteiba W; Parashar S; Vido DA; Merz CN
    Heart; 2009 Dec; 95(23):1901-6. PubMed ID: 19666461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study.
    Bairey Merz CN; Olson M; McGorray S; Pakstis DL; Zell K; Rickens CR; Kelsey SF; Bittner V; Sharaf BL; Sopko G
    J Womens Health Gend Based Med; 2000 Sep; 9(7):769-77. PubMed ID: 11025869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women's ischemia Syndrome Evaluation (WISE) Study.
    Sedlak TL; Johnson BD; Pepine CJ; Reis SE; Bairey Merz CN
    PLoS One; 2013; 8(9):e74585. PubMed ID: 24058592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Migraines, angiographic coronary artery disease and cardiovascular outcomes in women.
    Ahmed B; Bairey Merz CN; McClure C; Johnson BD; Reis SE; Bittner V; Pepine CJ; Sharaf BL; Sopko G; Kelsey SF; Shaw L;
    Am J Med; 2006 Aug; 119(8):670-5. PubMed ID: 16887413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.
    Arant CB; Wessel TR; Olson MB; Bairey Merz CN; Sopko G; Rogers WJ; Sharaf BL; Reis SE; Smith KM; Johnson BD; Handberg E; Mankad S; Pepine CJ;
    J Am Coll Cardiol; 2004 Jun; 43(11):2009-14. PubMed ID: 15172405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
    Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
    J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation.
    Marroquin OC; Kip KE; Kelley DE; Johnson BD; Shaw LJ; Bairey Merz CN; Sharaf BL; Pepine CJ; Sopko G; Reis SE;
    Circulation; 2004 Feb; 109(6):714-21. PubMed ID: 14970105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
    Arant CB; Wessel TR; Ridker PM; Olson MB; Reis SE; Delia Johnson B; Sharaf BL; Pauly DF; Handberg E; Zineh I; Sopko G; Kelsey SF; Noel Bairey Merz C; Pepine CJ
    Clin Cardiol; 2009 May; 32(5):244-50. PubMed ID: 19452486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Merz CN; Johnson BD; Berga SL; Braunstein GD; Azziz R; Yang Y; Reis SE; Bittner V; Hodgson TK; Pepine CJ; Sharaf BL; Sopko G; Kelsey SF;
    J Womens Health (Larchmt); 2009 Sep; 18(9):1315-22. PubMed ID: 19702477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease.
    Taqueti VR; Shaw LJ; Cook NR; Murthy VL; Shah NR; Foster CR; Hainer J; Blankstein R; Dorbala S; Di Carli MF
    Circulation; 2017 Feb; 135(6):566-577. PubMed ID: 27881570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).
    Mekonnen G; Hayek SS; Mehta PK; Li Q; Mahar E; Mou L; Kenkre TS; Petersen JW; Azarbal B; Samuels B; Anderson RD; Sedlak T; Zaya M; Agarwal M; Haftbaradaran A; Minissian M; Handberg E; Pepine CJ; Cogle CR; Bairey Merz CN; Waller EK; Quyyumi AA
    Atherosclerosis; 2016 Oct; 253():111-117. PubMed ID: 27596135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 10-Year Resource Utilization and Costs for Cardiovascular Care.
    Shaw LJ; Goyal A; Mehta C; Xie J; Phillips L; Kelkar A; Knapper J; Berman DS; Nasir K; Veledar E; Blaha MJ; Blumenthal R; Min JK; Fazel R; Wilson PWF; Budoff MJ
    J Am Coll Cardiol; 2018 Mar; 71(10):1078-1089. PubMed ID: 29519347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation).
    Sedlak T; Herscovici R; Cook-Wiens G; Handberg E; Wei J; Shufelt C; Bittner V; Reis SE; Reichek N; Pepine C; Bairey Merz CN
    J Am Heart Assoc; 2020 Apr; 9(7):e013234. PubMed ID: 32268814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation.
    Lee JJ; Cook-Wiens G; Johnson BD; Braunstein GD; Berga SL; Stanczyk FZ; Pepine CJ; Bairey Merz CN; Shufelt CL
    J Am Heart Assoc; 2019 Jun; 8(12):e012406. PubMed ID: 31165670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: findings from the National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Lewis JF; McGorray S; Lin L; Pepine CJ; Chaitman B; Doyle M; Edmundowicz D; Sharaf BL; Merz CN;
    Am Heart J; 2005 Mar; 149(3):527-33. PubMed ID: 15864243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events.
    Grace SL; Abbey SE; Irvine J; Shnek ZM; Stewart DE
    Psychother Psychosom; 2004; 73(6):344-52. PubMed ID: 15479989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.